Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2016 - 09 - 06

2016, Menarini invests in research and production in Italy and in Germany it expands its location

The Menarini Group continues to increase its investments in Italy and abroad. The Italian pharmaceutical company with headquarters in Florence has recently inaugurated several new buildings at its Berlin-based company, Berlin Chemie- Menarini.  The five new structures, some built ex novo and others renovated, represent an investment of €60 million over a total area of 14,000 square meters.

The new locations include: a company canteen which can seat up to 250 people and serve 650 meals a day; a pharmaceutical department dedicated to workers with disabilities which houses not only the manufacturing area, but also spaces designed for socializing and recreation for 35 employees and 5 assistants; a second access to the premises which includes a reception desk and shipping and receiving area; a new Quality Control building with 80 employees that will centralize all the company's quality control activities; a Technical Services building that will host the various workshops dedicated to the maintenance and support of the manufacturing processes accommodating 40 people.

The company canteen at Berlin-Chemie Menarini

The investment in Berlin Chemie – Menarini’s new structures began in 2013 and today more than 95% of the project has been completed.  It was presented to the German press and to various local authorities including the Mayor of the city of Berlin, Michael Müller, who is also Prime Minister of the city-state of Berlin. In Berlin, the Menarini Group has two manufacturing plants and an R & D center specializing in preclinical development and clinical research.

Berlin Chemie – Menarini, located in the German capital, is one of the company's worldwide locations acquired by Menarini in 1992 and represents the Italian pharmaceutical group’s continuous expansion in Germany and the most important countries in Central and Eastern Europe and Caucasia.  Thanks to these affiliates the Menarini Group is now present in more than 130 countries around the world.

"2016 was a year of major investments for the Menarini Group," commented Lucia Aleotti and Alberto Giovanni Aleotti, respectively President and Vice President of the Menarini Group.

"We are a company with an Italian heart and an increasingly international vision. This is demonstrated by our recent investments in Italy for VaxYnethic and Lodichem, respectively in the fields of vaccines and the manufacturing of pharmaceutical active ingredients, together with our renovation and expansion project of Berlin Chemie - Menarini.  One of our objectives since 1992, year in which this previously state-owned company was acquired, has been to work with highly experienced local management of the German market to whom we also conveyed the Italian entrepreneurial vision geared towards internationalization."

Michael Sirotovitch, Rainer Kern, Oliver Igel (Mayor of District Treptow-Köpenick),
Francesco Nuzzolo, Michael Müller (Mayor of Berlin), Reinhard Uppenkamp,
Christian Matschke, Attilio Sebastio, Piero Batacchi